Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Michael Zakrewsky"'
Autor:
Daniel Pan, Omayra Vargas-Morales, Blaine Zern, Aaron C Anselmo, Vivek Gupta, Michael Zakrewsky, Samir Mitragotri, Vladimir Muzykantov
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0152074 (2016)
Red blood cells (RBCs) can be used for vascular delivery of encapsulated or surface-bound drugs and carriers. Coupling to RBC prolongs circulation of nanoparticles (NP, 200 nm spheres, a conventional model of polymeric drug delivery carrier) enabling
Externí odkaz:
https://doaj.org/article/84781a3db4834519b1014695f0e05100
Autor:
Michael Zakrewsky, Patrick Hoopes
Publikováno v:
Journal of Pharmaceutical Sciences. 111:382-394
Sterilizing filtration is a common unit operation for the manufacture of parenteral drug products. However, filter performance can be impacted by properties of both the membrane material and the solution being filtered, requiring extensive multi-fact
Autor:
Dan Davis, Khaled AboulFotouh, Donna M. Williams, Mohammed Maniruzzaman, Yajie Zhang, Jieliang Wang, Michael Zakrewsky, Robert O. Williams, Akhilesh Bhambhani, Zhengrong Cui
Publikováno v:
Advanced drug delivery reviews. 172
Recent advances in formulation sciences have expanded the previously limited design space for biological modalities, including peptide, protein, and vaccine products. At the same time, the discovery and application of new modalities, such as cellular
Autor:
Michael Zakrewsky, Samir Mitragotri
Publikováno v:
Journal of Controlled Release. 242:80-88
The high prevalence of skin diseases and their visible symptoms result in major physical, emotional, and economic burden for which few solutions exist. To address this unmet medical need, topical delivery of RNAi such as siRNA holds many advantages i
Autor:
Sanjana Apte, Michael Zakrewsky, Amrita Banerjee, David T. Fox, Mattie R. Jones, Andrew T. Koppisch, Rico E. Del Sesto, Theresa L. Kern, Samir Mitragotri
Publikováno v:
Advanced Healthcare Materials. 5:1282-1289
Antiseptic agents are the primary arsenal to disinfect skin and prevent pathogens spreading within the host as well as into the surroundings; however the Food and Drug Administration published a report in 2015 requiring additional validation of nearl
Publikováno v:
Regenerative Engineering and Translational Medicine. 2:23-36
Keratinocytes are a targeted cell-type for treating skin disease. However, delivering drugs into the skin and keratinocytes remains challenging due to transport barriers posed by both the stratum corneum and cell membrane. Nonetheless, SPACE™ pepti
Publikováno v:
Journal of Controlled Release. 220:141-148
The immune system has evolved to recognize and respond to a wide variety of pathogens and produce distinct immune responses against diverse pathogenic structures. Despite remarkable advances, the general mechanisms by which the immune system differen
Publikováno v:
TECHNOLOGY. :214-238
Oral propranolol is commonly the first-line treatment of infantile hemangioma. However, oral delivery of propranolol is limited by systemic side effects, particularly in infants. Topical application may be a more patient friendly alternative while co
Autor:
Samir Mitragotri, Sunny Kumar, Joshua Sanchez De Oliveira, Michael Zakrewsky, Nino Ruocco, Stefano Menegatti, Gary L. Leal, Matthew E. Helgeson
Publikováno v:
Advanced Healthcare Materials. 4:2297-2305
Combinations of polymer conjugates affording in situ gelation hold promise for treatment of pathological cavities (e.g., arthritis) and sustained drug release. In particular, hyaluronic acid (HA) functionalized with reactive groups is regarded as an
Autor:
Michael Zakrewsky, John A. Muraski, Sunny Kumar, Ming Chen, Samir Mitragotri, Stefano Menegatti
Publikováno v:
Journal of Controlled Release. 199:168-178
Skin penetrating peptides (SPPs) have garnered wide attention in recent years and emerged as a simple and effective noninvasive strategy for macromolecule delivery into the skin. Although SPPs have demonstrated their potential in enhancing skin deliv